Merck & Co., Inc. to acquire NovaCardia, Inc.
Merck & Co., Inc. to Acquire NovaCardia
, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates; 07/25/2007; WHITEHOUSE STATION, N.J. and...
Merck snares NovaCardia in $350M buyout - FierceBiotech
Merck has bolstered its cardiovascular pipeline with a deal to buy NovaCardia
for $350 million in cash. For Merck, the acquisition marks another
Novacardia - San Diego, CA: Citysearch.com
Get details on Novacardia
- San Diego, CA, at Citysearch - over 1 million user reviews & editorials about local businesses.
Montreux Equity Partners: NovaCardia Raises $48 Million in Series B
Montreux Equity Partners is a life sciences venture capital firm focused on building great pharmaceutical and medical device companies.
domain-b.com : Merck buys cardiac biotech start-up NovaCardia
Merck is to acquire venture-backed NovaCardia
Inc for $350 million, adding a ... Woods said that NovaCardia
was prepared to take the drug to market by late 2009, ...
SignOnSanDiego.com > News > Business -- Merck to buy NovaCardia
Pharmaceutical giant Merck said Wednesday that it will buy NovaCardia
, a privately-held local biotechnology company with an experimental treatment for acute ...